Proposed Class Action – Mesoblast Limited (ASX:MSB)
A shareholder class action has been commenced against Mesoblast Limited (“MSB”) in the Federal Court of Australia.
ICP Funding Pty Ltd and Investor Claim Partner Pty Ltd are the respective funder and manager.
The action is being conducted by William Roberts Lawyers, on behalf of aggrieved MSB investors.
Claim Overview
The Class Action alleges that during the Relevant Period, Mesoblast engaged in unlawful conduct which misled the market about one of the company’s developmental stem cell therapies known as ‘Remestemcel-L’.
We consider that investors who acquired and held an interest in MSB shares during the Relevant Period (whether an interest in ASX-traded MSB shares or, a security that derived its value from ASX-traded MSB shares – together “MSB Security Holders“) have a reasonable basis to seek to recover from MSB the amount of losses they have suffered from the purchase of that interest.
| ASX Code: | MSB |
| ISIN: | AU000000MSB8 |
| Relevant Period: | 22 February 2018 to 17 December 2020 (inclusive) |
| Shares traded in Period | TBA |
Class Members
MSB Security Holders who acquired their interest in ASX-traded MSB shares during the period 22 February 2018 to 17 December 2020 (inclusive).
I think I have a claim. How do I participate in the proposed class action?
Click on the “REGISTER” button below to email us and register your expression of interest, to receive further information about the Class Action, including:
- how to participate; and
- updates about the progress of the class action.
REGISTER
By registering your expression of interest, you are indicating your interest in receiving further information about the class action. Registering your expression of interest is not a commitment by any party to participate in funded litigation.